Published in Med Hypotheses on December 04, 2010
Epistaxis and its complex origin. Med Hypotheses (2011) 0.75
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation (2009) 3.39
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29
The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk. Intern Emerg Med (2011) 2.12
Minimally invasive nonendoscopic thyroidectomy. Otolaryngol Head Neck Surg (2006) 1.56
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med (Hagerstown) (2014) 1.50
Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study. Intern Emerg Med (2013) 1.39
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk. Cardiovasc Drugs Ther (2005) 1.39
Idiopathic sudden hearing loss: another kind of circulatory risk should not be neglected. Eur Arch Otorhinolaryngol (2013) 1.39
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol (2011) 1.25
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens (2012) 1.04
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health (2010) 0.99
Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens (2006) 0.97
Secretory meningioma of the middle ear: a light microscopic, immunohistochemical and ultrastructural study of one case. Neuropathology (2008) 0.96
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. BMC Public Health (2011) 0.96
Central hemodynamic modifications in diabetes mellitus. Atherosclerosis (2013) 0.96
Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens (2007) 0.95
Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens (2014) 0.95
Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr Res (2013) 0.93
Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens (2010) 0.93
Transient hypoparathyroidism following thyroidectomy: a prospective study and multivariate analysis of 604 consecutive patients. Otolaryngol Head Neck Surg (2007) 0.93
Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol (2009) 0.90
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag (2007) 0.90
The value of neurostimulation and intraoperative nerve monitoring of inferior laryngeal nerve in thyroid surgery. Otolaryngol Head Neck Surg (2009) 0.90
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate. Arch Med Sci (2013) 0.89
Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study. BMC Cardiovasc Disord (2010) 0.88
Inner ear symptoms: can we use them to approach cardiovascular diseases? Intern Emerg Med (2014) 0.88
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium (2007) 0.88
Cardiometabolic Risks and Obesity in the Young. N Engl J Med (2016) 0.88
Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects. Arch Med Sci (2012) 0.87
An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum Mutat (2009) 0.87
Pulse pressure amplification, pressure waveform calibration and clinical applications. Atherosclerosis (2012) 0.86
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev (2013) 0.86
Accuracy of PTH assay and corrected calcium in early prediction of hypoparathyroidism after thyroid surgery. Otolaryngol Head Neck Surg (2008) 0.86
Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck (2008) 0.85
Hypotension as an isolated factor may not be sufficient to provoke hearing impairment. J Laryngol Otol (2004) 0.85
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials. Curr Opin Cardiol (2002) 0.85
Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens (2013) 0.85
Zofenopril and incidence of cough: a review of published and unpublished data. Ther Clin Risk Manag (2011) 0.84
[Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project]. G Ital Cardiol (Rome) (2007) 0.84
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens (2010) 0.84
Possible influence on heart rate on tinnitus. Med Hypotheses (2008) 0.83
Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study. J Womens Health (Larchmt) (2010) 0.83
Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals. Curr Hypertens Rep (2013) 0.82
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. Blood Press (2009) 0.82
Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study. High Blood Press Cardiovasc Prev (2014) 0.82
Three-dimensional reconstruction of the oral cavity using the free anterolateral thigh flap. Plast Reconstr Surg (2002) 0.82
How to avoid the depression of the adherence to antihypertensive treatment? J Hypertens (2013) 0.81
Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens (2013) 0.81
Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study. Intern Emerg Med (2014) 0.81
Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort. Obes Facts (2012) 0.80
Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control. High Blood Press Cardiovasc Prev (2013) 0.80
Heart disease and changes in pulse wave velocity and pulse pressure amplification in the elderly over 80 years: the PARTAGE Study. J Hypertens (2010) 0.80
Sensorineural hearing loss and celiac disease: a coincidental finding. Can J Gastroenterol (2009) 0.80
Could echocardiography yield a cardiovascular profile of the tinnitus prone subject? Med Hypotheses (2007) 0.79
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens (2007) 0.79
C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovasc Disord (2014) 0.79
Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome. Eur J Cardiovasc Prev Rehabil (2009) 0.79
Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med (Hagerstown) (2012) 0.79
Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers. J Altern Complement Med (2013) 0.78
Population health needs assessment and healthcare services use in a 3 years follow-up on administrative and clinical data: results from the Brisighella Heart Study. High Blood Press Cardiovasc Prev (2013) 0.78
Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects. Ann Nutr Metab (2016) 0.78
Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail (2014) 0.78
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study. Int J Cardiol (2011) 0.78
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study. Int J Endocrinol (2011) 0.78
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. Intern Emerg Med (2012) 0.78
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects. J Lipid Res (2012) 0.78
Global cardiovascular disease risk management in italian patients with metabolic syndrome in the clinical practice setting. High Blood Press Cardiovasc Prev (2013) 0.78
A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs (2015) 0.78
Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial. J Med Food (2010) 0.78
Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal angioplasty. J Endovasc Ther (2009) 0.78
Laryngeal neuromonitoring and neurostimulation versus neurostimulation alone in thyroid surgery: a randomized clinical trial. Head Neck (2011) 0.77
Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study. Metab Syndr Relat Disord (2013) 0.77
[Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension]. G Ital Cardiol (Rome) (2012) 0.77
Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. Adv Clin Exp Med (2013) 0.77
Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities. High Blood Press Cardiovasc Prev (2011) 0.77
Inner ear dysfunction of uncertain origin: a multidisciplinary approach could give something more. Med Hypotheses (2008) 0.77
Do we need 'new' omega-3 polyunsaturated fatty acids formulations? Expert Opin Pharmacother (2014) 0.77
Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. Fundam Clin Pharmacol (2009) 0.77
Serum LDL cholesterol levels and new onset of arterial hypertension: an 8-year follow-up. Eur J Clin Invest (2014) 0.76
Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation. Clin Exp Hypertens (2007) 0.76
Tinnitus as a warning for preventing vasovagal syncope. Med Hypotheses (2009) 0.76
Evolving concept of cardioprotection in myocardial infarction: from SMILE-1 to SMILE-5. Kardiol Pol (2013) 0.76
Serum uric acid and markers of low-density lipoprotein oxidation in nonsmoking healthy subjects: data from the Brisighella Heart Study. Pol Arch Med Wewn (2014) 0.76
Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Clin Exp Hypertens (2011) 0.76
An update on hypertensive emergencies and urgencies. J Cardiovasc Med (Hagerstown) (2015) 0.76
Renal artery denervation for treating resistant hypertension : definition of the disease, patient selection and description of the procedure. High Blood Press Cardiovasc Prev (2013) 0.75
Early and late angiotensin-converting enzyme inhibition after myocardial infarction: an overview of randomized clinical trials. Am J Med (2003) 0.75
Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus). BMC Cardiovasc Disord (2011) 0.75
Piezosurgery in otology: a promising device but not always the treatment of choice. Eur Arch Otorhinolaryngol (2011) 0.75
Is it the the renin-angiotensin-aldosterone blockade a comprehensive tool for the management of cardiovascular risk? J Hypertens (2004) 0.75
Idiopathic sudden sensorineural hearing loss and comorbid benign paroxysmal positional vertigo: some pathogenic additional considerations. Otol Neurotol (2012) 0.75
Diuretics in Meniere disease: a therapy or a potential cause of harm? Med Hypotheses (2011) 0.75
Central blood pressure as estimate of cardiovascular risk: potentials and limitations. J Hypertens (2008) 0.75
About plasma arginin vasopressin levels and Meniere's disease. Int J Audiol (2010) 0.75